Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis

Clinical Therapeutics

Volumn 18, Issue 2, 1996, Pages 265-272

  Banov, Charles H ^a,g   Silvers, William S ^b   Green, Andrew W ^c   Van Bavel, Julius H ^d   Winder, John A ^e   Feiss, Gary ^f   Simpson, Brandon ^f   Furst, John A ^f   Smith, Joseph A ^f  

^a Allerg Asthma Centers C   (United States)

^b Allerg Asthma Immunol Clin C   (United States)

^c Adult and Pediatric Allergy   (United States)

^d Allerg Assoc Austin Diagn Clin   (United States)

^e Allergy and Asthma Research Center   (United States)

^f SANOFI   (France)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRIAMCINOLONE ACETONIDE;

AEROSOL; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; GRASS POLLEN; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE OBSTRUCTION; NOSE SECRETION; PHARMACEUTICS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEASONAL VARIATION; SNEEZING; SYMPTOM;

EID: 0029902750     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80007-5     Document Type: Article

References (14)

1. Druce HM, Kaliner MA. Allergic rhinitis. JAMA. 1988;259:260-263.
2. Mabry RL. Corticosteroids in the management of upper respiratory allergy: The emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg. 1992;107: 855-860.
3. Naclerio RM. Allergic rhinitis. NEJM. 1991;325:860-869.
4. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol. 1988;81:984-991.
5. Feiss G, Morris R, Rom D, et al. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. J Allergy Clin Immunol. 1992;89: 1151-1156.
6. Findlay S, Huber F, Garcia J, Huang L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy. 1992;68:228-232.
7. Spector S, Bronsky E, Chervinsky P, et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy. 1990;64: 300-305.
8. Storms W, Bronsky E, Findlay S, et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy. 1991;66:329-334.
9. Tinkelman D, Falliers C, Gross G, et al. Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann Allergy. 1990;64:234-240.
10. Welch MJ, Bronsky EA, Findlay S, et al. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin Ther. 1994;16:253-262.
11. Welch MJ, Bronsky EA, Grossman J, et al. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy. 1991;67:493-498.
12. Sly RM. Pediatric Allergy. 2nd ed. Garden City, NY: Medical Examination Publishing Co, Inc; 1981:197.
13. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health. 1980;6:113-135.
14. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277.